128 related articles for article (PubMed ID: 2962792)
1. The remarkable proliferation of helper T cell subset in response to autologous thyrocytes and intrathyroidal T cells from patients with Graves' disease.
Eguchi K; Otsubo T; Kawabe Y; Ueki Y; Fukuda T; Matsunaga M; Shimomura C; Ishikawa N; Tezuka H; Nakao H
Clin Exp Immunol; 1987 Nov; 70(2):403-10. PubMed ID: 2962792
[TBL] [Abstract][Full Text] [Related]
2. Reduction in the suppressor-inducer T cell subset and increase in the helper T cell subset in thyroid tissue from patients with Graves' disease.
Ishikawa N; Eguchi K; Otsubo T; Ueki Y; Fukuda T; Tezuka H; Matsunaga M; Kawabe Y; Shimomura C; Izumi M
J Clin Endocrinol Metab; 1987 Jul; 65(1):17-23. PubMed ID: 2953751
[TBL] [Abstract][Full Text] [Related]
3. Human epidermal cells from ultraviolet light-exposed skin preferentially activate autoreactive CD4+2H4+ suppressor-inducer lymphocytes and CD8+ suppressor/cytotoxic lymphocytes.
Baadsgaard O; Fox DA; Cooper KD
J Immunol; 1988 Mar; 140(6):1738-44. PubMed ID: 2964481
[TBL] [Abstract][Full Text] [Related]
4. Synergy in antigen presentation by thyroid epithelial cells and monocytes from patients with Graves' disease.
Eguchi K; Otsubo T; Kawabe Y; Shimomura C; Ueki Y; Nakao H; Tezuka H; Matsunaga M; Fukuda T; Ishikawa N
Clin Exp Immunol; 1988 Apr; 72(1):84-90. PubMed ID: 3260842
[TBL] [Abstract][Full Text] [Related]
5. The decrease in non-specific suppressor T lymphocytes in female hyperthyroid Graves' disease is secondary to the hyperthyroidism.
Gerstein HC; Rastogi B; Iwatani Y; Iitaka M; Row VV; Volpé R
Clin Invest Med; 1987 Jul; 10(4):337-44. PubMed ID: 2888555
[TBL] [Abstract][Full Text] [Related]
6. Induction of circulating activated suppressor-like T cells by methimazole therapy for Graves' disease.
Tötterman TH; Karlsson FA; Bengtsson M; Mendel-Hartvig I
N Engl J Med; 1987 Jan; 316(1):15-22. PubMed ID: 2946953
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulation by methimazole therapy in Graves' disease: rapid changes in activation stage of circulating regulatory T cell subsets, B cells and NK cells.
Karlsson FA; Tötterman TH
Clin Exp Immunol; 1988 Nov; 74(2):258-63. PubMed ID: 2906281
[TBL] [Abstract][Full Text] [Related]
8. Correlation of immunoregulatory function with cell phenotype in cord blood lymphocytes.
Kingsley G; Pitzalis C; Waugh AP; Panayi GS
Clin Exp Immunol; 1988 Jul; 73(1):40-5. PubMed ID: 2971486
[TBL] [Abstract][Full Text] [Related]
9. Immunoregulatory T lymphocytes in man. Soluble antigen-specific suppressor-inducer T lymphocytes are derived from the CD4+CD45R-p80+ subpopulation.
Damle NK; Childs AL; Doyle LV
J Immunol; 1987 Sep; 139(5):1501-8. PubMed ID: 2887618
[TBL] [Abstract][Full Text] [Related]
10. Analysis of peripheral T lymphocyte subpopulations in Graves' disease.
Okabe N; Inoue K; Mori R
J Clin Lab Immunol; 1983 Feb; 10(2):91-5. PubMed ID: 6221106
[TBL] [Abstract][Full Text] [Related]
11. Interaction of lymphocytes and thyrocytes in Graves' disease and nonautoimmune thyroid diseases in immunohistochemical and ultrastructural investigations.
Ben-Skowronek I; Sierocinska-Sawa J; Szewczyk L; Korobowicz E
Horm Res; 2009; 71(6):350-8. PubMed ID: 19506393
[TBL] [Abstract][Full Text] [Related]
12. Effect of carbimazole treatment on specific and non-specific immunological parameters in patients with Graves' disease.
Charreire J; Karsenty G; Bouchard P; Schaison G
Clin Exp Immunol; 1984 Sep; 57(3):633-8. PubMed ID: 6147216
[TBL] [Abstract][Full Text] [Related]
13. Characterization of lymphoid cells in the thyroid of patients with Graves' disease.
Warford A; McLachlan SM; Malcolm AJ; Young ET; Farndon JR; Rees Smith B
Clin Exp Immunol; 1984 Sep; 57(3):626-32. PubMed ID: 6235996
[TBL] [Abstract][Full Text] [Related]
14. Immunological studies of autoimmune thyroid disorders: abnormalities in the inducer T cell subset and proliferative responses to autologous and allogeneic stimulation.
Fournier C; Chen H; Leger A; Charreire J
Clin Exp Immunol; 1983 Nov; 54(2):539-46. PubMed ID: 6228354
[TBL] [Abstract][Full Text] [Related]
15. Dysfunction of suppressor T cells in thyroid glands from patients with Graves' disease.
Ueki Y; Eguchi K; Fukuda T; Otsubo T; Kawabe Y; Shimomura C; Matsunaga M; Tezuka H; Ishikawa N; Ito K
J Clin Endocrinol Metab; 1987 Nov; 65(5):922-8. PubMed ID: 2959679
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic analyses and concanavalin-A-induced suppressor cell dysfunction of intrathyroidal lymphocytes from patients with Graves' disease.
Ueki Y; Eguchi K; Otsubo T; Kawabe Y; Shimomura C; Matsunaga M; Tezuka H; Nakao H; Kawakami A; Izumi M
J Clin Endocrinol Metab; 1988 Nov; 67(5):1018-24. PubMed ID: 2972737
[TBL] [Abstract][Full Text] [Related]
17. The T4 molecule differentially regulating the activation of subpopulations of T4+ cells.
Takeuchi T; Schlossman SF; Morimoto C
J Immunol; 1987 Aug; 139(3):665-71. PubMed ID: 2955047
[TBL] [Abstract][Full Text] [Related]
18. Intrathyroidal T cell clones from patients with autoimmune thyroid disease.
MacKenzie WA; Schwartz AE; Friedman EW; Davies TF
J Clin Endocrinol Metab; 1987 Apr; 64(4):818-24. PubMed ID: 2880865
[TBL] [Abstract][Full Text] [Related]
19. Immunoregulatory T cell circuits in man. Identification of a distinct T cell subpopulation of the helper/inducer lineage that amplifies the development of alloantigen-specific suppressor T cells.
Damle NK; Mohagheghpour N; Kansas GS; Fishwild DM; Engleman EG
J Immunol; 1985 Jan; 134(1):235-43. PubMed ID: 3155461
[TBL] [Abstract][Full Text] [Related]
20. [Intrathyroidal lymphocytes in autoimmune thyroid diseases].
Aguayo J; Wohlik N; Baeza A; Carrasco AM; Pineda G
Rev Med Chil; 1994 Jan; 122(1):19-26. PubMed ID: 8066339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
